Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report
Atypical teratoid rhabdoid tumor (ATRT) is a rare and highly aggressive embryonal tumor of the central nervous system with a dismal prognosis and no definitive guidelines for treatment, especially at relapse or in case of refractory disease. Metronomic chemotherapy (MC) has emerged as a new treatmen...
Main Authors: | Mahe Berland, Laetitia Padovani, Angélique Rome, Grégoire Pech-Gourg, Dominique Figarella-Branger, Nicolas André |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00792/full |
Similar Items
-
Atypical teratoid rhabdoid tumor: current therapy and future directions
by: Kevin F. Ginn, et al.
Published: (2012-09-01) -
Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
by: Huy Minh Tran, et al.
Published: (2020-03-01) -
Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid
by: Mariah M. Hoffman, et al.
Published: (2020-03-01) -
Metronomics: Intrinsic Anakoinosis Modulator?
by: André Nicolas, et al.
Published: (2018-06-01) -
Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
by: Prabhat Singh Malik, et al.
Published: (2014-04-01)